Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Insite Vision Inc. -- Ignore unavailable to you. Want to Upgrade?

To: bob s who wrote (595)	12/26/1997 11:20:00 AM
From: David Bogdanoff	Read Replies (1) \| Respond to of 1060

BS: Some months ago I recall that MM recommended buying calls and puts on NVX; has he now switched to just plain shorting it? Was this shorting recommendation with his shorting newsletter? NVX has a big short position which now accounts for its historically low price, so MM is not alone in his short opinion, but it appears to be a change from his previous hedge strategy. There have been previous posts on this thread explaining the confusion in interpretation of clinical trials which has led to this degree of shorting. David